Suppr超能文献

大型肾上腺肿瘤的个体化手术:从微创到开放(混合)入路

Tailored surgery for large adrenal tumors: the minimally invasive to open (hybrid) approach.

作者信息

Dukaczewska Agata, Ilgner Konrad, Kunze Catarina Alisa, Sladek Jennifer, Dobrindt Eva Maria, Goretzki Peter E, Pratschke Johann, Mogl Martina T, Butz Frederike

机构信息

Department of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, 10117, Berlin, Germany.

Department of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.

出版信息

Updates Surg. 2025 Aug 29. doi: 10.1007/s13304-025-02388-7.

Abstract

Conversion from minimally invasive techniques to open surgery has mostly been considered as an undesirable event associated with intraoperative complications or poor preoperative planning. However, the impact of conversion to open surgery during adrenalectomy for large adrenal tumours remains unclear. This study investigates the outcomes of conversion from minimally invasive to open surgery for adrenal masses ≥ 60 mm with an additional focus on the identification of survival predictors in patients with large adrenocortical carcinoma (ACC). We retrospectively analyzed 97 patients who underwent unilateral adrenalectomy for tumours ≥ 60 mm. Patient characteristics, tumour features, surgical approaches, and outcomes were compared. Survival outcomes in ACC patients (n = 34) were assessed using Kaplan-Meier analysis, with prognostic factors evaluated via univariate Cox regression and Ridge Regression modeling. Of 97 patients, 41 (42%) underwent minimally invasive adrenalectomy (MIA), 40 (41%) open adrenalectomy (OA), and 16 (17%) required conversion to open surgery (hybrid adrenalectomy, HA). HA had a longer operative time (median 226.5 vs. 108.5 min; p < 0.001) and hospital stay (median 9 vs. 4 days; p < 0.001) compared to MIA but not OA (median 188 min; p = 0.102; 10 days; p = 0.519, respectively). Overall, complications were more frequent in HA (43.7%) than MIA (7.3%; p = 0.003) but similar to OA (37.5%; p = 0.897). Minor complications were more common in HA than MIA (31 vs. 7%; p = 0.032), while major complications were comparable (12.5 vs. 7.5%; p = 0.617). Tumours in HA cases more often showed vascular infiltration (p = 0.001) and required multivisceral resection (p = 0.002). ENSAT tumour stage (OS: HR = 4.66, p = 0.041; PFS: HR = 2.52, p = 0.005) and the S-GRAS score (OS: HR = 6.00; PFS: HR = 1.50) were significant survival predictors in ACC, whereas the operative technique was not. Conversion to open surgery increases minor complications compared to MIA but not OA. ENSAT tumour stage and S-GRAS score predict survival in ACC, while the surgical approach does not. Timely conversion should be performed to ensure oncological safety when needed.

摘要

从微创技术转换为开放手术大多被视为与术中并发症或术前规划不佳相关的不良事件。然而,对于大型肾上腺肿瘤行肾上腺切除术时转换为开放手术的影响仍不明确。本研究调查了直径≥60mm的肾上腺肿块从微创转换为开放手术的结果,并特别关注大肾上腺皮质癌(ACC)患者生存预测因素的识别。我们回顾性分析了97例因肿瘤≥60mm接受单侧肾上腺切除术的患者。比较了患者特征、肿瘤特征、手术方式和结果。使用Kaplan-Meier分析评估ACC患者(n = 34)的生存结果,通过单因素Cox回归和岭回归模型评估预后因素。97例患者中,41例(42%)接受了微创肾上腺切除术(MIA),40例(41%)接受了开放肾上腺切除术(OA),16例(17%)需要转换为开放手术(杂交肾上腺切除术,HA)。与MIA相比,HA的手术时间更长(中位数226.5 vs. 108.5分钟;p < 0.001),住院时间更长(中位数9 vs. 4天;p < 0.001),但与OA相比无差异(中位数188分钟;p = 0.102;10天;p = 0.519)。总体而言,HA的并发症比MIA更常见(43.7%比7.3%;p = 0.003),但与OA相似(37.5%;p = 0.897)。HA中的轻微并发症比MIA更常见(31%比7%;p = 0.032),而严重并发症相当(12.5%比7.5%;p = 0.617)。HA病例中的肿瘤更常显示血管浸润(p = 0.001),需要多脏器切除(p = 0.002)。在ACC中,ENSAT肿瘤分期(总生存期:HR = 4.66,p = 0.041;无进展生存期:HR = 2.52,p = 0.005)和S-GRAS评分(总生存期:HR = 6.00;无进展生存期:HR = 1.50)是显著的生存预测因素,而手术技术不是。与MIA相比,转换为开放手术会增加轻微并发症,但与OA相比不会。ENSAT肿瘤分期和S-GRAS评分可预测ACC的生存,而手术方式不能。必要时应及时进行转换以确保肿瘤学安全性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验